These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1678880

  • 1. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
    Cagnacci A, Melis GB, Soldani R, Bonuccelli U, Piccini P, Napolitano A, Muratorio A, Fioretti P.
    Neuroendocrinology; 1991 Jun; 53(6):549-55. PubMed ID: 1678880
    [Abstract] [Full Text] [Related]

  • 2. Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using naloxone.
    Melis GB, Paoletti AM, Gambacciani M, Mais V, Fioretti P.
    Neuroendocrinology; 1984 Jul; 39(1):60-3. PubMed ID: 6087184
    [Abstract] [Full Text] [Related]

  • 3. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women.
    Cagnacci A, Melis GB, Paoletti AM, Soldani R, Fioretti P.
    J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330
    [Abstract] [Full Text] [Related]

  • 4. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME, Sheehan KL, Casper RF, Yen SS.
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [Abstract] [Full Text] [Related]

  • 5. Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.
    Fioretti P, Cagnacci A, Paoletti AM, Gambacciani M, Soldani R, Mauro GA, Spinetti A, Melis GB.
    J Endocrinol Invest; 1989 May; 12(5):295-301. PubMed ID: 2549113
    [Abstract] [Full Text] [Related]

  • 6. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy.
    De Leo V, Petraglia F, Bruno MG, Lanzetta D, Inaudi P, D'Antona N.
    Gynecol Obstet Invest; 1989 May; 27(2):94-8. PubMed ID: 2499519
    [Abstract] [Full Text] [Related]

  • 7. [The role of the endogenous opioid system in the pathogenesis of polycystic ovary syndrome: the altered neuroendocrine regulation of GnRH-LH is corrected after clomiphene therapy].
    Barletta C, Vagiri D, Scavo D.
    Minerva Endocrinol; 1992 May; 17(3):107-19. PubMed ID: 1298870
    [Abstract] [Full Text] [Related]

  • 8. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B, Rozbicka G, Jeske W, Abdel-Fattah MH.
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [Abstract] [Full Text] [Related]

  • 9. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
    Barbarino A, De Marinis L, Tofani A, Della Casa S, D'Amico C, Mancini A, Corsello SM, Sciuto R, Barini A.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
    [Abstract] [Full Text] [Related]

  • 10. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
    Rossmanith WG, Mortola JF, Yen SS.
    J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
    [Abstract] [Full Text] [Related]

  • 11. Thermoregulatory and endocrine effects of a low dose of danazol in postmenopausal women: interaction with the effect of naloxone.
    Cagnacci A, Melis GB, Paoletti AM, Soldani R, Fioretti P.
    Life Sci; 1991 Oct; 48(11):1051-8. PubMed ID: 1900094
    [Abstract] [Full Text] [Related]

  • 12. Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride.
    Melis GB, Cagnacci A, Gambacciani M, Paoletti AM, Moggi L, Fioretti P.
    J Clin Endocrinol Metab; 1988 May; 66(5):964-7. PubMed ID: 2834413
    [Abstract] [Full Text] [Related]

  • 13. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women.
    Shoupe D, Montz FJ, Lobo RA.
    J Clin Endocrinol Metab; 1985 Jan; 60(1):178-83. PubMed ID: 2981084
    [Abstract] [Full Text] [Related]

  • 14. Alcohol effects on naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolactin plasma levels in female rhesus monkeys.
    Mello NK, Mendelson JH, Bree MP, Skupny A.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):895-904. PubMed ID: 3133465
    [Abstract] [Full Text] [Related]

  • 15. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
    Petraglia F, De Leo V, Nappi C, Facchinetti F, Montemagno U, Brambilla F, Genazzani AR.
    J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
    [Abstract] [Full Text] [Related]

  • 16. Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal women.
    Melis GB, Cagnacci A, Gambacciani M, Paoletti AM, Caffi T, Fioretti P.
    Neuroendocrinology; 1988 Feb; 47(2):159-63. PubMed ID: 2830551
    [Abstract] [Full Text] [Related]

  • 17. Endogenous opioid peptide regulation of pulsatile luteinizing hormone secretion during pregnancy in the rat.
    Devorshak-Harvey E, Bona-Gallo A, Gallo RV.
    Neuroendocrinology; 1987 Nov; 46(5):369-78. PubMed ID: 3323939
    [Abstract] [Full Text] [Related]

  • 18. Endogenous opiates modulate pulsatile luteinizing hormone release in humans.
    Ropert JF, Quigley ME, Yen SS.
    J Clin Endocrinol Metab; 1981 Mar; 52(3):583-5. PubMed ID: 6780598
    [Abstract] [Full Text] [Related]

  • 19. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI, Winter JS, Faiman C.
    Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845
    [Abstract] [Full Text] [Related]

  • 20. Effect of sodium valproate on luteinizing hormone secretion in pre- and postmenopausal women and its modulation by naloxone infusion.
    Popovic V, Spremovic-Radjenovic S, Eric-Marinkovic J, Grossman A.
    J Clin Endocrinol Metab; 1996 Jul 01; 81(7):2520-4. PubMed ID: 8675571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.